IMUX
IMMUNIC (IMUX)
NASDAQ
$15.04-$0.03 (-0.17%)
Price as of Jun 23, 2026 7:45 PM EDT
  • $200.9M
    Market Cap
  • 112.85%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-82.0M
+2.42%
-80.0M
-3.81%
-83.2M
+16.78%
-71.3M
+16.59%
Depreciation and Amortization Expense
168,000
+25.37%
134,000
+20.72%
111,000
+44.16%
77,000
-9.41%
Total Operating Expenses
103.2M
+5.28%
98.1M
-1.18%
99.2M
-16.96%
119.5M
+30.35%
Operating Profit
-103.2M
+5.28%
-98.1M
-1.18%
-99.2M
-16.96%
-119.5M
+30.35%
Interest Income
1.0M
-69.32%
3.4M
+10.24%
3.1M
+195.39%
1.0M
+1,477.27%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
1.0M
-69.32%
3.4M
+10.24%
3.1M
+195.39%
1.0M
+1,477.27%
Total Nonoperating Income and Expense
6.1M
+346.68%
-2.5M
-143.75%
5.6M
+710.55%
-919,000
-28.20%
Income before Taxes
-103.2M
+5.28%
-98.1M
-1.18%
-99.2M
-16.96%
-119.5M
+30.35%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-97.2M
-3.32%
-100.5M
+7.37%
-93.6M
-22.25%
-120.4M
+29.55%
Net Income from Continuing Operations Applicable to Common
-97.2M
-3.32%
-100.5M
+7.37%
-93.6M
-22.25%
-120.4M
+29.55%
Basic EPS and Net Income
-0.62
-38.00%
-1.00
-52.61%
-2.11
-44.18%
-3.78
-3.82%
Diluted EPS and Net Income
-0.62
-38.00%
-1.00
-52.61%
-2.11
-44.18%
-3.78
-3.82%
Basic Weighted Average Shares
155.7M
+55.42%
100.2M
+126.03%
44.3M
+39.29%
31.8M
+34.53%
Diluted Weighted Average Shares
155.7M
+55.42%
100.2M
+126.03%
44.3M
+39.29%
31.8M
+34.53%
Balance Sheet
Cash and Cash Equivalents
15.5M
-56.59%
35.7M
-23.58%
46.7M
-56.28%
106.7M
+22.89%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
15.5M
-56.59%
35.7M
-23.58%
46.7M
-56.28%
106.7M
+22.89%
Total Current Assets
22.9M
-41.86%
39.3M
-25.13%
52.5M
-58.26%
125.9M
+19.88%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
608,000
+11.56%
545,000
+16.95%
466,000
+58.50%
294,000
+93.42%
Total Long-Term Assets
608,000
+11.56%
545,000
N/A
0
-100.00%
43,000
+2.38%
Total Assets
24.1M
-41.15%
40.9M
-24.74%
54.3M
-57.50%
127.8M
-8.16%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
30.6M
+38.07%
22.2M
-10.33%
24.7M
+89.10%
13.1M
+14.70%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
107,000
-59.47%
264,000
-58.69%
639,000
-35.58%
992,000
+69.86%
Total Liabilities
30.7M
+36.93%
22.4M
-11.55%
25.4M
+80.31%
14.1M
+17.39%
Retained Earnings
-608.6M
+19.00%
-511.4M
+24.46%
-410.9M
+29.50%
-317.3M
+61.16%
Total Stockholders Equity
-6.7M
-136.21%
18.4M
-36.30%
28.9M
-74.55%
113.7M
-10.57%
Total Shares Outstanding
90.2M
0.00%
90.2M
+99.55%
45.2M
+14.93%
39.3M
+49.26%
Cash Flow
Cash from Operating Activities
-85.8M
+1.23%
-84.8M
+19.68%
-70.8M
+8.73%
-65.1M
-21.73%
Capital Expenditures
161,000
-39.02%
264,000
-20.96%
334,000
+198.21%
112,000
+67.16%
Cash from Investing Activities
-161,000
-39.02%
-264,000
-102.79%
9.5M
+197.14%
-9.7M
+14,438.81%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
65.6M
-12.03%
74.5M
+7,115.97%
1.0M
-98.92%
95.8M
+123.52%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-299.36%
+41.73%
-211.22%
+105.39%
-102.84%
+13.96%
-90.24%
+49.02%
Return on Equity
-1,653.15%
+289.49%
-424.44%
+223.31%
-131.28%
+31.27%
-100.01%
+53.81%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.75
-57.89%
1.77
-16.51%
2.12
-77.93%
9.62
+4.52%
Cash Ratio
0.51
-68.56%
1.61
-14.78%
1.89
-76.88%
8.16
+7.14%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow